Tissue-Link ApS
CVR 40633979 · Private limited company (ApS) · Active · Medium risk
Tissue-Link ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.9% over the next 12 months, which is 1.3 times the average for Danish companies. 7 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -853k and a net result of DKK -772k. CEO: Peter Aadal Nielsen.
Bankruptcy risk for Tissue-Link ApS
1.3 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40633979
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Tagensvej 22
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 313k
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 7 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -24.1% |
| Current ratio | 602% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -818k | DKK -399k |
| Net profit | DKK -772k | DKK -319k |
| Equity | DKK -853k | DKK -82k |
| Total assets | DKK 3.5m | DKK 1.4m |
| Cash | DKK 2.3m | – |
| Short-term debt | DKK 588k | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 58 | ||
| 1 Jan 2024 – 31 Dec 2024 | 70 | ||
| 1 Jan 2023 – 31 Dec 2023 | 40 | ||
| 1 Jan 2022 – 31 Dec 2022 | 88 | ||
| 1 Jan 2021 – 31 Dec 2021 | 130 | ||
| 1 Jan 2020 – 31 Dec 2020 | 82 | ||
| 24 Jun 2019 – 31 Dec 2019 | 111 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Peter Aadal Nielsen | Current | |
| Board | Charlotte Videbæk | Current | |
| Board | Peter Aadal Nielsen | Current | |
| Board | Niels Ole Mikkelsen | Current | |
| Board | Kurt Bækgaard Osther | ||
| Board | Pär Ingemar Johansson | ||
| Board | Lars Ploug Hansen | ||
| Owner (20%) | Kurt Bækgaard Osther | Current | |
| Owner (20%) | AADALBIOTECH ApS | Current | |
| Owner (20%) | LGM WINTHER HOLDING ApS | Current | |
| Owner (20%) | C- ApS | Current | |
| Owner (20%) | Trial-Lab Holding AB | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | Current | |
| Founder | Kurt Bækgaard Osther | Current | |
| Founder | AADALBIOTECH ApS | Current | |
| Founder | C- ApS | Current | |
| Founder | Trial-Lab Holding AB | Current |
The CEOs' other companies
Peter Aadal Nielsen – 2 other companies, of which 1 bankrupt
- ENTOMOPHARM ApS Bankrupt 11 Apr 2014
- AADALBIOTECH ApS Active
Address history (1 moves)
| Tagensvej 22, 2200 København N | |
| c/o Peter Aadal Nielsen, Harhoffs Alle 38, 4100 Ringsted |
Other companies at the same address
- Inscripta Denmark ApS Bankrupt
- CHEMPARTNER EUROPE ApS Active
- STATGROUP ApS Active
- Unwired Things ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about Tissue-Link ApS
Has Tissue-Link ApS gone bankrupt?
No, Tissue-Link ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Tissue-Link ApS?
Our model estimates a bankruptcy risk of 1.9% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.
Who is the CEO of Tissue-Link ApS?
Peter Aadal Nielsen is the CEO of Tissue-Link ApS.
Who is the auditor of Tissue-Link ApS?
Tissue-Link ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was Tissue-Link ApS founded?
Tissue-Link ApS was founded on 24 June 2019.
What is the equity of Tissue-Link ApS?
Equity was DKK -853k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.